Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    Alpers' Disease
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Prehospital Resuscitation Intranasal Cooling Effects Seen in MRI of the Brain After Cardiac Arrest
Condition: Cardiac Arrest
Intervention:
2 Enrolling by invitation A Long-Term Extension Study of RP103-MITO-001 to Assess RP103 in Children With Inherited Mitochondrial Disease
Condition: Mitochondrial Diseases
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules
3 Enrolling by invitation Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial Disease
Condition: Inherited Mitochondrial Disease, Including Leigh Syndrome
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
4 Recruiting Combination of Multiparametric MRI and Electrophysiology for the Development of New Biomarkers in Spinal Cord Diseases
Condition: Spinal Cord Disease
Intervention: Procedure: Combination of multiparametric MRI and electrophysiology
5 Recruiting North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Conditions: Mitochondrial Disorders;   Mitochondrial Genetic Disorders;   Mitochondrial Diseases;   Disorder of Mitochondrial Respiratory Chain Complexes;   Deletion and Duplication of Mitochondrial DNA
Intervention:
6 Unknown  Mechanisms of Panic Disorders Treatment
Conditions: Panic Disorder;   Agoraphobia;   Panic Attacks
Intervention: Behavioral: Cognitive Behavioural Therapy (CBT)

Study has passed its completion date and status has not been verified in more than two years.